CMAB BioPharma
Chemicals & Related Products · China · 201-500 Employees
View Company Info for Free
Overview
Headquarters
34-37 Connaught Rd Central, Central and ...Phone Number
+86 51267995188Website
www.cmabbio.comRevenue
$40.7 MillionIndustry
About CMAB BioPharma
CMAB BioPharma Org Chart
Is CMAB BioPharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
CMAB BioPharma, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if CMAB BioPharma had a recent Job posting/layoffs
Check out if CMAB BioPharma is spiking on competitors!
Funding: Get notified immidiatlly once CMAB BioPharma has new funding data
Check if CMAB BioPharma has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at CMAB BioPharma
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when CMAB BioPharma launches new products
Earning: See what the market has to say on CMAB BioPharma recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
CMAB BioPharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
CMAB BioPharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about CMAB BioPharma.
CMAB BioPharma Tech Stack
A closer look at the technologies used by CMAB BioPharma
CMAB BioPharma News & Media
CMAB Biopharma Congratulates Partner Innovent Biologics on FDA Clearance of IND Application of its COVID-19 Antibody Project
SUZHOU, China, March 2, 2021 /PRNewswire/ -- CMAB Biopharma (Suzhou) Inc ("CMAB") congratulates its partner Innovent Biologics, Inc ("Innovent") (1801.HK) on the U.S. Food and Drug Administration (FDA) clearance of an Investigational New Drug (IND) application for its antibody candidate...CMAB Biopharma Congratulates QureBio on FDA Clearance of IND Application for Claudin18.2/PD-L1 Bispecific Antibody
SUZHOU, China, March 2, 2021 /PRNewswire/ -- Recently, CMAB Biopharma (Suzhou) Inc's ("CMAB") partner QureBio Ltd ("QureBio") has announced its innovative drug Q-1802 received United States Food and Drug Administration (FDA) clearance for an Investigational New Drug (IND) application....CMAB Biopharma and Laekna Therapeutics Enter Strategic Agreement for LAE005 Global Development and Commercialization Partnership
SUZHOU, China, Sept. 10, 2020 /PRNewswire/ -- CMAB Biopharma (Suzhou) Inc. ("CMAB"), and Laekna Therapeutics Shanghai Co., Ltd. ("Laekna Therapeutics"), today announced a strategic collaboration agreement in Suzhou BioBAY for speedup of Immune Checkpoint Inhibitor (ICI) drug candidate to...
Top Chemicals & Related Products Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding CMAB BioPharma
CMAB is a full-service CDMO dedicated to providing bespoke development and manufacturing services for antibodies and biologics for clients in China and across the globe. Our adaptable, service-oriented business enables clients to take their innovative concepts for tomorrow's medicines from DNA to clinical product today. To find out more about our f... Read More